Tfc Financial Management Abbott Laboratories Transaction History

Tfc Financial Management

$722 Million
Q2 2025

A detailed history of Tfc Financial Management transactions in Abbott Laboratories stock. As of the latest transaction made, Tfc Financial Management holds 7,580 shares of ABT stock, worth $974,409. This represents 0.14% of its overall portfolio holdings.

Number of Shares

7,580

Previous 7,441 1.87%

Holding current value

$974,409

Previous $987,000 4.36%

% of portfolio

0.14%

Previous 0.15%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 29, 2025	BUY	$123.95 - $138.08 $17,229 - $19,193	139 Added 1.87%	7,580 $1.03 Million
Q1 2025 Apr 24, 2025	SELL	$111.1 - $140.22 $13,776 - $17,387	-124 Reduced 1.64%	7,441 $987,000
Q4 2024 Jan 29, 2025	SELL	$111.93 - $119.39 $9,290 - $9,909	-83 Reduced 1.09%	7,565 $855,000
Q3 2024 Oct 24, 2024	SELL	$100.07 - $118.13 $9,006 - $10,631	-90 Reduced 1.16%	7,648 $871,000
Q2 2024 Jul 23, 2024	SELL	$100.73 - $112.44 $35,658 - $39,803	-354 Reduced 4.37%	7,738 $804,000
Q1 2024 Apr 30, 2024	SELL	$109.52 - $120.96 $33,951 - $37,497	-310 Reduced 3.69%	8,092 $919,000
Q4 2023 Jan 25, 2024	SELL	$90.19 - $110.4 $27,868 - $34,113	-309 Reduced 3.55%	8,402 $924,000
Q3 2023 Oct 23, 2023	BUY	$95.53 - $114.62 $7,833 - $9,398	82 Added 0.95%	8,711 $843,000
Q2 2023 Aug 07, 2023	BUY	$100.78 - $112.29 $11,589 - $12,913	115 Added 1.35%	8,629 $940,000
Q1 2023 May 08, 2023	SELL	$96.86 - $114.01 $5,036 - $5,928	-52 Reduced 0.61%	8,514 $862,000
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $61,598 - $72,264	-648 Reduced 7.03%	8,566 $940,000
Q3 2022 Oct 21, 2022	SELL	$96.76 - $112.03 $13,739 - $15,908	-142 Reduced 1.52%	9,214 $892,000
Q1 2022 May 04, 2022	BUY	$114.02 - $139.04 $30,785 - $37,540	270 Added 2.97%	9,356 $1.11 Million
Q4 2021 Feb 02, 2022	BUY	$115.53 - $141.46 $5,545 - $6,790	48 Added 0.53%	9,086 $1.28 Million
Q3 2021 Nov 02, 2021	BUY	$116.66 - $129.06 $300,749 - $332,716	2,578 Added 39.91%	9,038 $1.07 Million
Q2 2021 Jul 29, 2021	BUY	$105.79 - $124.53 $6,347 - $7,471	60 Added 0.94%	6,460 $749,000
Q4 2020 Feb 10, 2021	BUY	$105.0 - $114.42 $13,230 - $14,416	126 Added 2.01%	6,400 $701,000
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $574,949 - $698,233	6,274 New	6,274 $683,000

Others Institutions Holding ABT

# of Institutions

3,575

Shares Held

1.38B

Call Options Held

9.72M

Put Options Held

8.83M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $225B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tfc Financial Management, based on Form 13F filings with the SEC.

News

Stay updated on Tfc Financial Management with notifications on news.

Account

Tfc Financial Management Abbott Laboratories Transaction History